Can Vitamin B12 Cause High Blood Pressure?

Standard vitamin B12 supplements taken by mouth at typical doses do not raise blood pressure. The relationship between B12 and blood pressure is more tangled than that simple answer suggests, though. One particular form of B12 given intravenously at massive doses can briefly push blood pressure up, while B12 deficiency itself may contribute to vascular problems through a separate pathway involving homocysteine. A recent cross-sectional analysis of American adults even found a statistical link between higher dietary B12 intake and greater odds of hypertension, a finding that complicates the picture further.

What Ordinary B12 Supplements Do to Blood Pressure

If you are taking a cyanocobalamin or methylcobalamin tablet, sublingual lozenge, or even a periodic injection for a diagnosed deficiency, the evidence does not point to any meaningful increase in blood pressure. A study of vegetarians with low B12 status found that after supplementation, B12 levels rose and homocysteine fell, but blood pressure did not change significantly in either direction.¹ Pharmacokinetic testing of an oral cyanocobalamin formulation reported no adverse events at all.² In practical terms, the pills and sublingual tabs you find at a pharmacy are not a blood-pressure concern.

This makes sense physiologically. Oral B12 is absorbed in tiny amounts through the gut, and your body is efficient at excreting what it does not need. Blood levels of B12 can rise considerably with supplementation, but the mechanisms that would translate that into higher blood pressure require concentrations far beyond what a pill delivers.

The Hydroxocobalamin Exception

There is one form of B12 that clearly can raise blood pressure: hydroxocobalamin, administered intravenously at very high doses. This is not something you would encounter as a supplement. Hydroxocobalamin is used in emergency medicine, most famously as an antidote for cyanide poisoning, where it is infused in gram-level quantities directly into the bloodstream.

In a study of 41 healthy volunteers receiving intravenous hydroxocobalamin, blood pressure rose shortly after the infusion began, tracked closely with plasma concentrations of the drug, and returned nearly to baseline within about four hours.³ The rise was temporary and dose-dependent. Meanwhile, a study of patients in vasodilatory shock (a life-threatening condition where blood vessels lose their ability to constrict) found that a single bolus of hydroxocobalamin did not produce a lasting change in blood pressure at 24 hours.⁴

The proposed mechanism behind this temporary spike is that hydroxocobalamin binds nitric oxide, a molecule your blood vessels use to relax and widen. When nitric oxide gets mopped up, blood vessels constrict and pressure climbs.⁵ Researchers have actually explored this property as a potential treatment for dangerously low blood pressure during cardiac surgery and organ transplantation, turning a side effect into a therapeutic tool. But this effect requires intravenous delivery of gram-scale doses, not the microgram quantities in a daily supplement. Unless you are in an emergency department receiving IV hydroxocobalamin, this mechanism is irrelevant to your blood pressure.

How B12 Deficiency Might Hurt Your Blood Vessels

Paradoxically, being low in B12 may be worse for your cardiovascular system than having plenty of it. The key link is homocysteine, an amino acid that your body normally recycles using B12 and folate. When B12 is low, homocysteine accumulates in the blood. Elevated homocysteine has long been associated with atherosclerosis and hypertension, and laboratory and animal studies have demonstrated that it can damage blood vessel walls, trigger inflammation, and impair the ability of arteries to dilate properly.⁶

A trial that gave B vitamins (including B12 and folate) to people with elevated homocysteine found that homocysteine levels dropped significantly and flow-mediated dilatation, a measure of how well arteries relax, improved. The improvement in artery function tracked specifically with the drop in free homocysteine rather than with changes in B12 or folate levels themselves.⁷ In other words, B12 helped blood vessels, but indirectly, by keeping homocysteine from accumulating.

The frustrating part of this story is that lowering homocysteine has not reliably translated into fewer heart attacks and strokes in large clinical trials. A randomized trial in patients with end-stage renal disease found that high-dose folic acid, B12, and B6 supplementation did not reduce total mortality and had no significant effect on cardiovascular events, despite presumably lowering homocysteine.⁸ This disconnect between improving a biomarker and improving actual health outcomes has been debated for over two decades and remains unresolved.

The Cross-Sectional Puzzle: Higher B12 Intake Linked to More Hypertension

A large cross-sectional study of American adults found something that seems to cut against the grain of everything above. When researchers looked at dietary B12 intake across the population, higher intake was associated with greater odds of hypertension. People in the highest intake brackets had roughly 40 percent higher odds of hypertension compared to those in the lowest bracket in the overall population. In younger adults aged 20 to 39, the association was even stronger, and certain mid-range intake quartiles showed strikingly elevated odds.⁹

Before you toss your B12 supplements, it is worth understanding what this kind of study can and cannot tell you. A cross-sectional analysis looks at a snapshot in time: people who eat more B12-rich food also tend to eat more meat, often have different overall dietary patterns, and may differ in weight, physical activity, and a dozen other variables that affect blood pressure. The association could easily reflect something about the diets or lifestyles that come packaged with high B12 intake, not B12 itself. This study also found that B12 was negatively associated with diastolic pressure in people over 60, which adds to the sense that the relationship is not straightforward.

Cross-sectional studies are good at generating hypotheses but poor at proving cause and effect. The interventional evidence (supplementation trials that directly measured what happened to blood pressure) consistently shows no increase. That discrepancy suggests confounding rather than a true causal effect of B12 on blood pressure.

When B12 Deficiency Drops Blood Pressure Too Low

Severe B12 deficiency can actually cause dangerously low blood pressure rather than high blood pressure. Case reports have documented patients presenting with orthostatic hypotension, the kind of dramatic blood pressure drop when standing that causes dizziness and fainting, as a direct consequence of B12 deficiency. In one case, a patient with pernicious anemia and autonomic neuropathy from B12 deficiency experienced recurrent fainting episodes; after B12 replacement therapy with cyanocobalamin, blood pressure returned to normal.¹⁰ A similar case described a woman whose orthostatic symptoms resolved with B12 replacement.¹¹

The mechanism here involves nerve damage. B12 is essential for maintaining the myelin sheath that insulates nerve fibers, and when it deteriorates, the autonomic nerves that regulate blood vessel tone can malfunction. Your body loses its ability to tighten blood vessels when you stand, and blood pools in your legs. This is a recognized if underappreciated neurological consequence of prolonged B12 deficiency, and it underscores the irony: if anything, severe B12 deficiency is more likely to give you a blood pressure problem on the low side than the high side.

What High Serum B12 Levels Actually Mean

A finding that sometimes alarms people is that elevated serum B12 levels have been linked to worse cardiovascular outcomes, including higher mortality. In an analysis of hypertensive adults, those with elevated B12 had roughly 40 percent higher risk of all-cause death and about three times the risk of cardiovascular death compared to those with lower levels.¹² Even after excluding people who might have B12 metabolic deficiency driving up their levels, the association held.

This sounds frightening, but the explanation is almost certainly not that B12 is toxic to your heart. High serum B12 is frequently a marker of underlying disease rather than a cause of it. Liver damage, kidney failure, certain blood cancers, and chronic inflammatory conditions can all raise circulating B12 levels because the organs that store or clear B12 are not working properly. In someone with hypertension who also has liver or kidney problems, the high B12 is a red flag that something else is going wrong, not evidence that B12 itself is doing damage. Researchers have described this as a “reverse causation” problem: the disease drives the biomarker up, not the other way around.

Methylcobalamin and Arterial Stiffness

Not all forms of B12 are equivalent in their effects on blood vessels. A randomized trial in patients on long-term hemodialysis compared intravenous methylcobalamin to folate for their effects on asymmetric dimethylarginine (ADMA), a compound that inhibits nitric oxide production and is associated with arterial stiffness. Methylcobalamin reduced ADMA levels by about 25 percent, compared to roughly 13 percent for folate alone, and only the methylcobalamin group showed a decrease in arterial stiffness.¹³ These patients also saw normalization of their elevated homocysteine.

Arterial stiffness is closely related to blood pressure: stiffer arteries make it harder for the heart to pump blood efficiently and tend to raise systolic pressure over time. A form of B12 that reduces stiffness would, if anything, work against hypertension rather than promote it. This study was small and limited to dialysis patients, so it should not be generalized broadly, but it adds another piece of evidence suggesting B12 is more friend than foe to your cardiovascular system.

B12 in Pregnancy and Preeclampsia

Preeclampsia is a serious pregnancy complication characterized by dangerously high blood pressure. The relationship between B12 and preeclampsia is an active area of research, and the evidence is not entirely consistent. A systematic review and meta-analysis pooling multiple studies found that women with preeclampsia had significantly lower B12 levels than healthy pregnant women, with a mean difference of about 15 pg/mL.¹⁴ The researchers noted high heterogeneity between the individual studies, which means the results varied a lot from study to study.

Adding to the confusion, at least one study found the opposite pattern: higher maternal B12 levels in women with preeclampsia, particularly in those who delivered preterm.¹⁵ That same study also found higher folate and homocysteine in the preeclampsia group, which complicates interpretation further. The disagreement between studies could reflect differences in population, timing of blood sampling, or the complex metabolic changes pregnancy induces. What is clear is that B12 status during pregnancy matters, but whether low or high levels contribute to preeclampsia risk remains genuinely unsettled.

Dietary B12 and Blood Pressure in Children

An interesting piece of the puzzle comes from outside the adult population entirely. A study of Japanese preschool children found that those in the highest quartile of dietary B12 intake had systolic blood pressure about 6.6 mmHg lower and diastolic blood pressure about 5.7 mmHg lower than children in the lowest quartile. Higher folic acid intake showed a similar but smaller pattern for systolic pressure.¹⁶

A difference of nearly 7 mmHg in systolic pressure is substantial, especially in young children where the range of normal blood pressure is narrower. This observational association ran in the opposite direction from the American adult cross-sectional study described earlier, which found higher B12 intake linked to higher blood pressure. The difference could be explained by the dramatically different dietary contexts: Japanese preschool diets are quite different from typical American adult diets, and the confounders that travel with high B12 intake (heavy red meat consumption, processed food, higher calorie diets) may not apply in the same way to small children eating fish and seaweed.

Genetics and Individual Variation

Your genes influence how you metabolize B12, and some of that genetic variation intersects with blood pressure regulation. Research into the TCN2 gene, which encodes transcobalamin II, the protein that carries B12 in your blood, found that a specific variant appeared to have a protective effect against hypertension. People carrying the A allele of one particular variant had lower hypertension risk than those with the more common genotype.¹⁷ The MTHFR gene, well known for its role in folate metabolism (which is tightly coupled to B12 metabolism), was also investigated in the same study for blood pressure associations.

What this tells us practically is limited but conceptually important: the way your body handles B12 is partially determined by your genetics, and those same genetic pathways touch blood pressure regulation. Two people taking the same B12 supplement could, in theory, have somewhat different vascular responses. This is a long way from being clinically actionable, though. No doctor is testing your TCN2 variants before recommending a B12 supplement. It is more a reminder that population-level findings about B12 and blood pressure may not map neatly onto every individual.

Practical Takeaways for People Monitoring Their Blood Pressure

If you have hypertension and are wondering whether your B12 supplement is making things worse, the interventional evidence is reassuring: oral B12 at standard supplemental doses has not been shown to raise blood pressure in any controlled trial. The forms you are most likely to encounter (cyanocobalamin and methylcobalamin in pill, sublingual, or intramuscular injection form) have clean safety profiles with respect to blood pressure.

If your doctor has flagged unusually high serum B12 on a blood test and you are not taking supplements, that is worth investigating, not because B12 is hurting you, but because elevated serum B12 can signal liver disease, kidney dysfunction, or other conditions that independently affect cardiovascular health. The high B12 is the messenger, not the culprit.

If you are severely deficient in B12, restoring normal levels is likely to help rather than harm your cardiovascular system. Deficiency allows homocysteine to build up and can damage the autonomic nerves that help regulate blood pressure. Correcting the deficiency addresses both of those problems. Whether that translates into fewer heart attacks and strokes is a bigger and still-open question, but at the level of vascular function and blood pressure stability, repletion appears to be beneficial.

The one genuine scenario where B12 raises blood pressure, intravenous hydroxocobalamin at emergency-medicine doses, is not something you will encounter outside a hospital. If you do receive it (say, for cyanide exposure from a house fire), the blood pressure effect is expected, monitored by the medical team, and temporary. It is not a reason to worry about the B12 in your daily multivitamin or your monthly injection.